US2799241A
(en)
|
1949-01-21 |
1957-07-16 |
Wisconsin Alumni Res Found |
Means for applying coatings to tablets or the like
|
US4160861A
(en)
|
1977-10-03 |
1979-07-10 |
Merck & Co., Inc. |
Method for the separation of antibiotic macrolides
|
US4584369A
(en)
|
1981-07-31 |
1986-04-22 |
Sloan-Kettering Institute For Cancer Research |
Anti-leukemic beta-glycosyl C-nucleosides
|
JPS5939889A
(ja)
|
1982-08-30 |
1984-03-05 |
Noguchi Kenkyusho |
2,4,6↓−トリ↓−0↓−アセチル↓−3↓−デオキシ↓−ヘキソノ↓−1,5↓−ラクトンの製造方法
|
JP2544609B2
(ja)
|
1986-10-07 |
1996-10-16 |
和光純薬工業株式会社 |
Tcnq錯体
|
US4863957A
(en)
|
1987-12-21 |
1989-09-05 |
Rorer Pharmaceutical Corporation |
Novel HMG-CoA reductase inhibitors
|
CA1327013C
(en)
|
1988-06-23 |
1994-02-15 |
Peter Rex Brawn |
Cosmetic composition
|
JP2786896B2
(ja)
|
1988-08-19 |
1998-08-13 |
ワーナー―ランバート・コンパニー |
置換されたジヒドロイソキノリノンおよび関連化合物
|
DE59105613D1
(de)
*
|
1990-08-24 |
1995-07-06 |
Spirig Ag |
Verfahren zur Herstellung von Pellets.
|
JPH04253974A
(ja)
|
1991-02-05 |
1992-09-09 |
Ishihara Sangyo Kaisha Ltd |
スルホニル尿素系化合物、それらの製造方法及びそれらを含有する除草剤
|
EP0517969A1
(en)
|
1991-06-10 |
1992-12-16 |
AUSIMONT S.p.A. |
Process for increasing the bleaching efficiency of an inorganic persalt or of hydrogen peroxide
|
US5149838A
(en)
|
1991-09-20 |
1992-09-22 |
Merck & Co., Inc. |
Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents
|
US5610294A
(en)
|
1991-10-11 |
1997-03-11 |
The Du Pont Merck Pharmaceutical Company |
Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
|
ZA927272B
(en)
|
1991-10-29 |
1994-03-23 |
Du Pont |
Herbicidal triazolecarboxamides
|
GB9208161D0
(en)
|
1992-04-14 |
1992-05-27 |
Pfizer Ltd |
Indoles
|
US5334225A
(en)
|
1992-07-15 |
1994-08-02 |
Kao Corporation |
Keratinous fiber dye composition containing a 2-substituted amino-5-alkylphenol derivative coupler
|
CA2102591C
(en)
|
1992-11-12 |
2000-12-26 |
Kenji Tsujihara |
Hypoglycemic agent
|
US5731292A
(en)
|
1992-11-12 |
1998-03-24 |
Tanabe Seiyaku Co., Ltd. |
Dihydrochalcone derivatives which are hypoglycemic agents
|
DE4243279A1
(de)
|
1992-12-21 |
1994-06-23 |
Bayer Ag |
Substituierte Triole
|
US6297363B1
(en)
|
1993-02-12 |
2001-10-02 |
Nomura Co., Ltd. |
Glycoside indoles
|
JP3342727B2
(ja)
|
1993-03-01 |
2002-11-11 |
株式会社小松製作所 |
制振鋼板の曲げ加工方法および曲げ加工装置
|
JP3187611B2
(ja)
|
1993-05-17 |
2001-07-11 |
キヤノン株式会社 |
液晶性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた表示方法および表示装置
|
JPH07242526A
(ja)
|
1994-03-03 |
1995-09-19 |
Sogo Yatsukou Kk |
化粧料
|
US5830873A
(en)
|
1994-05-11 |
1998-11-03 |
Tanabe Seiyaku Co., Ltd. |
Propiophenone derivative and a process for preparing the same
|
JPH09509680A
(ja)
|
1994-09-30 |
1997-09-30 |
ジ・オハイオ・ステイト・リサーチ・ファウンデーション |
N−(4−ヒドロキシフェニル)レチンアミド−o−グルクロニドのc−グリコシド類似物
|
US5780483A
(en)
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
CA2236007A1
(en)
|
1995-10-31 |
1997-07-17 |
Gerald Floyd Smith |
Antithrombotic diamines
|
JP3059088B2
(ja)
|
1995-11-07 |
2000-07-04 |
田辺製薬株式会社 |
プロピオフェノン誘導体およびその製法
|
US5723495A
(en)
|
1995-11-16 |
1998-03-03 |
The University Of North Carolina At Chapel Hill |
Benzamidoxime prodrugs as antipneumocystic agents
|
JPH09263549A
(ja)
|
1996-01-25 |
1997-10-07 |
Fujisawa Pharmaceut Co Ltd |
ベンゼン誘導体の製造法
|
IL121525A0
(en)
|
1996-08-26 |
1998-02-08 |
Tanabe Seiyaku Co |
Process for preparing optically active benzothiazepine compound and intermediate therefor
|
ES2176600T3
(es)
|
1996-12-26 |
2002-12-01 |
Tanabe Seiyaku Co |
Derivado de la propiofenona y procedimientos para su preparacion.
|
US6153632A
(en)
|
1997-02-24 |
2000-11-28 |
Rieveley; Robert B. |
Method and composition for the treatment of diabetes
|
AU6422298A
(en)
|
1997-03-25 |
1998-10-20 |
Takeda Chemical Industries Ltd. |
Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
|
CN1203846C
(zh)
|
1998-03-19 |
2005-06-01 |
布里斯托尔-迈尔斯斯奎布公司 |
高溶解性药物的双相控释递送系统和方法
|
PE20000559A1
(es)
|
1998-05-27 |
2000-07-05 |
Merck & Co Inc |
Formulacion de tabletas comprimidas de efavirenz
|
EP1087931A1
(de)
|
1998-06-18 |
2001-04-04 |
MERCK PATENT GmbH |
Verfahren zur symmetrischen und unsymmetrischen disubstitution von carbonsäureamiden mit organotitanaten und grignard-reagenzien
|
FR2780403B3
(fr)
|
1998-06-24 |
2000-07-21 |
Sanofi Sa |
Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
|
JP2000034239A
(ja)
|
1998-07-16 |
2000-02-02 |
Asahi Glass Co Ltd |
トリフルオロメチル化芳香族化合物の製造方法
|
JP3857429B2
(ja)
|
1998-07-17 |
2006-12-13 |
ポーラ化成工業株式会社 |
含硫黄抗真菌剤
|
US6069238A
(en)
|
1998-09-30 |
2000-05-30 |
Eli Lilly And Company |
Spirocyclic C-glycosides
|
JP2002529455A
(ja)
|
1998-11-09 |
2002-09-10 |
ジェームズ・ブラック・ファウンデーション・リミテッド |
ガストリンおよびコレシストキニン受容体リガンド類
|
CZ20011629A3
(cs)
|
1998-11-12 |
2001-12-12 |
Smithkline Beecham Plc |
Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků
|
US20020032164A1
(en)
|
1998-12-30 |
2002-03-14 |
Dale Roderic M. K. |
Antimicrobial compounds and methods for their use
|
GB9912961D0
(en)
|
1999-06-03 |
1999-08-04 |
Pfizer Ltd |
Metalloprotease inhibitors
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
US6586438B2
(en)
|
1999-11-03 |
2003-07-01 |
Bristol-Myers Squibb Co. |
Antidiabetic formulation and method
|
BR0015294A
(pt)
|
1999-11-03 |
2003-07-15 |
Bristol Myers Squibb Co |
Método para tratamento da diabetes
|
JP3450810B2
(ja)
|
2000-01-31 |
2003-09-29 |
キヤノン株式会社 |
脂肪族ポリエステル、脂肪族ポリエステルの製造方法およびセルロースの再資源化方法
|
JP4456768B2
(ja)
|
2000-02-02 |
2010-04-28 |
壽製薬株式会社 |
C−配糖体を含有する薬剤
|
US6627611B2
(en)
|
2000-02-02 |
2003-09-30 |
Kotobuki Pharmaceutical Co Ltd |
C-glycosides and preparation of thereof as antidiabetic agents
|
AU3217501A
(en)
|
2000-03-03 |
2001-09-12 |
Pfizer Prod Inc |
Pyrazole ether derivatives as anti-inflammatory/analgesic agents
|
NZ521369A
(en)
|
2000-03-17 |
2004-07-30 |
Kissei Pharmaceutical |
Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
|
US6683056B2
(en)
|
2000-03-30 |
2004-01-27 |
Bristol-Myers Squibb Company |
O-aryl glucoside SGLT2 inhibitors and method
|
US6555519B2
(en)
|
2000-03-30 |
2003-04-29 |
Bristol-Myers Squibb Company |
O-glucosylated benzamide SGLT2 inhibitors and method
|
GB0011098D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Pharmaceutical compositions comprising protpn pump inhibitors and gastrin/cholecystokinin receptor ligands
|
EP1172362A1
(de)
|
2000-07-11 |
2002-01-16 |
Basf Aktiengesellschaft |
Azadioxacycloalkene und ihre Verwendung zur Bekämpfung von Schadpilzen und tierischen Schädlingen
|
KR100426030B1
(ko)
|
2000-07-22 |
2004-04-03 |
(주) 한켐 |
락톤계 당화합물에서의 키랄성 전환방법
|
EP1326829A2
(en)
|
2000-09-29 |
2003-07-16 |
Bayer Pharmaceuticals Corporation |
17-beta-hydroxysteroid dehydrogenase-ii inhibitors
|
DE60141156D1
(de)
|
2000-11-02 |
2010-03-11 |
Ajinomoto Kk |
Neue pyrazolderivate und diese enthaltende mittel gegen diabetes
|
JP2002167430A
(ja)
|
2000-12-01 |
2002-06-11 |
Canon Inc |
脂肪族ポリエステル、脂肪族ポリエステルの製造方法およびデンプンの資源化方法
|
US6476352B2
(en)
|
2000-12-18 |
2002-11-05 |
General Electric Company |
Laser beam stop sensor and method for automatically detecting the presence of laser beam stop material using a laser beam stop sensor
|
EP1354888B1
(en)
|
2000-12-28 |
2009-05-20 |
Kissei Pharmaceutical Co., Ltd. |
Glucopyranosyloxypyrazole derivatives and use thereof in medicines
|
CA2438593C
(en)
|
2001-02-26 |
2010-09-21 |
Kissei Pharmaceutical Co., Ltd. |
Glucopyranosyloxypyrazole derivatives and medicinal use thereof
|
ES2350084T3
(es)
|
2001-02-27 |
2011-01-18 |
Kissei Pharmaceutical Co., Ltd. |
Derivados de glucopiranosiloxipirazol y uso médico de los mismos.
|
JP4190290B2
(ja)
|
2001-03-02 |
2008-12-03 |
ユニバーシティー オブ ウエスタン オンタリオ |
放射能標識された化合物のポリマー前駆体、ならびにその作製および使用法
|
US6936590B2
(en)
|
2001-03-13 |
2005-08-30 |
Bristol Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
ES2258141T3
(es)
|
2001-04-11 |
2006-08-16 |
Bristol-Myers Squibb Company |
Complejos de aminoacidos de glucosidos c-arilo para el tratamiento de la diabetes y procedimiento.
|
CA2445346C
(en)
|
2001-04-27 |
2010-04-06 |
Ajinomoto Co., Inc. |
N-substituted pyrazole-o-glycoside derivatives and therapeutic agent for diabetes containing the same
|
GB0112122D0
(en)
|
2001-05-18 |
2001-07-11 |
Lilly Co Eli |
Heteroaryloxy 3-substituted propanamines
|
US7105556B2
(en)
|
2001-05-30 |
2006-09-12 |
Bristol-Myers Squibb Company |
Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
|
CA2455300A1
(en)
|
2001-06-20 |
2003-01-03 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
|
JP4115105B2
(ja)
|
2001-07-02 |
2008-07-09 |
協和醗酵工業株式会社 |
ピラゾール誘導体
|
WO2003011880A1
(fr)
|
2001-07-31 |
2003-02-13 |
Kissei Pharmaceutical Co., Ltd. |
Derive de glucopyranosyloxybenzylbenzene, composition medicinale contenant ce derive, usage medicinal de cette composition et produit intermediaire pour produire cette composition
|
US20030191121A1
(en)
|
2001-08-09 |
2003-10-09 |
Miller Ross A. |
Piperazine carboxamide intermediates of HIV protease inhibitors and processes for their preparation
|
WO2003020737A1
(en)
|
2001-09-05 |
2003-03-13 |
Bristol-Myers Squibb Company |
O-pyrazole glucoside sglt2 inhibitors and method of use
|
ATE312940T1
(de)
|
2001-10-24 |
2005-12-15 |
Michael Burton |
Chromogenischen enzymsubstraten und verfahren zum nachweis von beta-d-ribofuranosidase-wirksamkeit
|
NZ532478A
(en)
|
2001-11-08 |
2007-02-23 |
Sepracor Inc |
Methods for treating depression and other CNS disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
|
EA009281B1
(ru)
|
2001-11-16 |
2007-12-28 |
Катаникс Корпорейшн |
Фармацевтические и косметические композиции, содержащие ароматические альдегиды, содержащие оксигруппу
|
JP2003238417A
(ja)
|
2002-02-18 |
2003-08-27 |
Nippon Shoyaku Kenkyusho:Kk |
フロレチン配糖体の安定化組成物、該安定化組成物を含有する糖尿病予防・治療剤、および保健食品
|
US6617313B1
(en)
|
2002-03-13 |
2003-09-09 |
Council Of Scientific And Industrial Research |
Glucopyranoside and process of isolation thereof from pterocarpus marsupium pharmaceutical composition containing the same and use thereof
|
US6562791B1
(en)
|
2002-03-29 |
2003-05-13 |
Council Of Scientific And Industrial Research |
Glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
|
MXPA04010190A
(es)
|
2002-04-18 |
2005-02-03 |
Astrazeneca Ab |
Compuestos heterociclicos.
|
JP2003313168A
(ja)
|
2002-04-18 |
2003-11-06 |
Kirin Brewery Co Ltd |
Bcl−2阻害活性を有する化合物およびその化合物のスクリーニング方法
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
TWI254635B
(en)
|
2002-08-05 |
2006-05-11 |
Yamanouchi Pharma Co Ltd |
Azulene derivative and salt thereof
|
EP1528066A4
(en)
|
2002-08-09 |
2007-05-02 |
Taisho Pharmaceutical Co Ltd |
ARYL-t-THIO-B-GLUCOPYRANOSIDE DERIVATIVES AND DIABETES CONTAINING THEM
|
JP4606876B2
(ja)
|
2002-08-27 |
2011-01-05 |
キッセイ薬品工業株式会社 |
ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
|
CA2501239A1
(en)
|
2002-10-07 |
2004-04-22 |
Encore Pharmaceuticals, Inc. |
R-nsaid esters and their use
|
IN192749B
(zh)
|
2002-11-15 |
2004-05-15 |
Ranbaxy Lab Ltd |
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
US7375213B2
(en)
|
2003-01-03 |
2008-05-20 |
Bristol-Myers Squibb Company |
Methods of producing C-aryl glucoside SGLT2 inhibitors
|
GB0301259D0
(en)
|
2003-01-20 |
2003-02-19 |
Novartis Ag |
Organic compounds
|
US7164015B2
(en)
|
2003-02-27 |
2007-01-16 |
Bristol-Myers Squibb Company |
Non-cryogenic process for forming glycosides
|
WO2004080990A1
(ja)
|
2003-03-14 |
2004-09-23 |
Astellas Pharma Inc. |
C-グリコシド誘導体又はその塩
|
JP2004300102A
(ja)
|
2003-03-31 |
2004-10-28 |
Kissei Pharmaceut Co Ltd |
縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途
|
AU2003902263A0
(en)
|
2003-05-12 |
2003-05-29 |
Fujisawa Pharmaceutical Co., Ltd. |
Monosaccharide compounds
|
WO2004113359A1
(ja)
|
2003-06-20 |
2004-12-29 |
Kissei Pharmaceutical Co., Ltd. |
ピラゾール誘導体、それを含有する医薬組成物及びその製造中間体
|
TWI376370B
(en)
|
2003-07-23 |
2012-11-11 |
Synta Pharmaceuticals Corp |
Compounds for inflammation and immune-related uses
|
DK2896397T4
(da)
|
2003-08-01 |
2020-11-16 |
Mitsubishi Tanabe Pharma Corp |
Nye forbindelser med hæmmende aktivitet mod natriumafhængig glukosetransportør
|
EA010655B1
(ru)
|
2003-08-01 |
2008-10-30 |
Янссен Фармацевтика Н.В. |
Замещенные индазол-о-глюкозиды
|
US7129220B2
(en)
|
2003-08-01 |
2006-10-31 |
Janssen Pharmaceutica N.V |
Substituted indole-O-glucosides
|
US8785403B2
(en)
|
2003-08-01 |
2014-07-22 |
Mitsubishi Tanabe Pharma Corporation |
Glucopyranoside compound
|
AR048376A1
(es)
|
2003-08-01 |
2006-04-26 |
Janssen Pharmaceutica Nv |
C- glicosidos heterociclos fusionados sustituidos
|
UA86042C2
(en)
|
2003-08-01 |
2009-03-25 |
Янссен Фармацевтика Н.В. |
Substituted indazole-o-glucosides
|
EP1679966A4
(en)
|
2003-08-01 |
2009-05-27 |
Janssen Pharmaceutica Nv |
BENZIMIDAZOLE-, BENZTRIAZOLE- AND BENZIMIDAZOLONE-SUBSTITUTED O-GLUCOSIDES
|
WO2005058845A2
(en)
|
2003-12-19 |
2005-06-30 |
Novo Nordisk A/S |
Novel glucagon antagonists/inverse agonists
|
US7157584B2
(en)
|
2004-02-25 |
2007-01-02 |
Takeda Pharmaceutical Company Limited |
Benzimidazole derivative and use thereof
|
CA2557801C
(en)
|
2004-03-16 |
2013-06-25 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
|
JP5017103B2
(ja)
|
2004-06-17 |
2012-09-05 |
トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド |
薬剤共結晶組成物および関連した使用方法
|
US7393836B2
(en)
|
2004-07-06 |
2008-07-01 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
|
EP1773800A1
(de)
|
2004-07-27 |
2007-04-18 |
Boehringer Ingelheim International GmbH |
D-glucopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
WO2006018150A1
(de)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
WO2006082523A2
(en)
|
2005-01-25 |
2006-08-10 |
Aurobindo Pharma Limited |
Pharmaceutical sustained release composition of metformin
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
ATE445608T1
(de)
|
2005-02-23 |
2009-10-15 |
Boehringer Ingelheim Int |
Glucopyranosylsubstituierte ((hetero)arylethynyl- benzyl)-benzenderivative und deren verwendung als inhibitoren des natriumabhängigen glucose- cotransporters typ 2 (sglt2)
|
ATE453656T1
(de)
|
2005-04-15 |
2010-01-15 |
Boehringer Ingelheim Int |
Glucopyranosyl-substituierte (heteroaryloxy- benzyl)-benzen-derivate als sglt-inhibitoren
|
US7772191B2
(en)
|
2005-05-10 |
2010-08-10 |
Boehringer Ingelheim International Gmbh |
Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
|
JP2007023099A
(ja)
|
2005-07-13 |
2007-02-01 |
Yokohama Rubber Co Ltd:The |
ノルボルネン系樹脂用1液型ウレタン接着剤組成物ならびにノルボルネン系樹脂用弾性接着剤およびその使用方法
|
JP5128474B2
(ja)
|
2005-07-27 |
2013-01-23 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコピラノシル−置換((ヘテロ)シクロアルキルエチニル−ベンジル)−ベンゼン誘導体、該化合物を含有する薬剤、それらの使用及びそれらの製造方法
|
DE602006017566D1
(de)
|
2005-08-30 |
2010-11-25 |
Boehringer Ingelheim Pharma |
Glucopyranosyl-substituierte benzyl-derivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
|
AR056195A1
(es)
|
2005-09-15 |
2007-09-26 |
Boehringer Ingelheim Int |
Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
|
CN101057835A
(zh)
|
2005-09-26 |
2007-10-24 |
刘凤鸣 |
二甲双胍格列本脲的缓释制剂
|
AU2007208239B2
(en)
|
2006-01-25 |
2013-04-18 |
Synta Pharmaceuticals Corp. |
Substituted aromatic compounds for inflammation and immune-related uses
|
TWI370818B
(en)
|
2006-04-05 |
2012-08-21 |
Astellas Pharma Inc |
Cocrystal of c-glycoside derivative and l-proline
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
TWI418556B
(zh)
|
2006-07-27 |
2013-12-11 |
Mitsubishi Tanabe Pharma Corp |
吲哚衍生物
|
WO2008020011A1
(en)
|
2006-08-15 |
2008-02-21 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
|
CA2664095A1
(en)
|
2006-09-21 |
2008-03-27 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
KR100812538B1
(ko)
|
2006-10-23 |
2008-03-11 |
한올제약주식회사 |
약물 제어방출형 메트포르민-글리메피리드 복합제제
|
WO2008055870A1
(en)
|
2006-11-06 |
2008-05-15 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
|
BRPI0718596B8
(pt)
|
2006-11-09 |
2021-05-25 |
Boehringer Ingelheim Int |
composições farmacêuticas para terapia de combinação com inibidores de sglt-2 e metformina
|
ES2397664T3
(es)
|
2006-12-04 |
2013-03-08 |
Janssen Pharmaceutica, N.V. |
Derivados de glucopiranósilo que contienen tienilo como antidiabéticos
|
UY30730A1
(es)
|
2006-12-04 |
2008-07-03 |
Mitsubishi Tanabe Pharma Corp |
Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
|
EP1956023A1
(en)
|
2007-02-06 |
2008-08-13 |
Lonza Ag |
Method for lithium exchange reactions
|
JP2010521492A
(ja)
|
2007-03-15 |
2010-06-24 |
ネクティド,インク. |
徐放性ビグアニド組成物、および即時性ジペプチジルペプチダーゼiv阻害剤組成物を含む抗糖尿病合剤
|
AR065809A1
(es)
|
2007-03-22 |
2009-07-01 |
Bristol Myers Squibb Co |
Formulaciones farmaceuticas que contienen un inhibidor sglt2
|
JP5424571B2
(ja)
*
|
2007-04-12 |
2014-02-26 |
協和発酵キリン株式会社 |
トピラマート含有固形製剤
|
WO2008136393A1
(ja)
*
|
2007-04-27 |
2008-11-13 |
Ajinomoto Co., Inc. |
ラクタム化合物の結晶形およびその製造方法
|
US20090047514A1
(en)
|
2007-08-15 |
2009-02-19 |
Allen David P |
Thermal Activated Pressure Sensitive Adhesive and Method for Producing the Same and Product therewith
|
CL2008002425A1
(es)
*
|
2007-08-16 |
2009-09-11 |
Boehringer Ingelheim Int |
Composición farmacéutica que comprende un inhibidor de sglt2 y 1-(4-metil-quinazolin-2-il)metil-3metil-7-(-2-butin-1-il)-8-(3-(r)-amino-piperidin-1il)-xantina, un inhibidor de dpp iv y su uso para el tratamiento de la obesidad y de la diabetes tipo 1 y 2 y complicaciones de esta.
|
ES2647504T3
(es)
|
2007-09-10 |
2017-12-21 |
Janssen Pharmaceutica N.V. |
Proceso para la preparación de compuestos útiles como inhibidores de SGLT
|
CL2008003653A1
(es)
*
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
|
AR071175A1
(es)
|
2008-04-03 |
2010-06-02 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
|
KR101512386B1
(ko)
|
2008-04-08 |
2015-04-17 |
제이더블유중외제약 주식회사 |
미티글리나이드 및 메트포르민 복합제제 및 그의 제조방법
|
JP6071198B2
(ja)
|
2008-07-15 |
2017-02-01 |
テラコス,インコーポレーテッド |
重水素化ベンジルベンゼン誘導体及び使用方法
|
NZ591818A
(en)
|
2008-08-22 |
2013-01-25 |
Theracos Inc |
Processes for the preparation of sglt2 inhibitors
|
US9056850B2
(en)
|
2008-10-17 |
2015-06-16 |
Janssen Pharmaceutica N.V. |
Process for the preparation of compounds useful as inhibitors of SGLT
|
WO2010045656A2
(en)
|
2008-10-17 |
2010-04-22 |
Nectid, Inc. |
Novel sglt2 inhibitor dosage forms
|
WO2010092125A1
(en)
|
2009-02-13 |
2010-08-19 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof
|
EA201171279A1
(ru)
*
|
2009-04-24 |
2012-05-30 |
Айсьютика Пти Лтд. |
Производство инкапсулированных наночастиц с высокой объемной долей
|
US20110009347A1
(en)
|
2009-07-08 |
2011-01-13 |
Yin Liang |
Combination therapy for the treatment of diabetes
|
CN102648196B
(zh)
|
2009-10-14 |
2016-04-27 |
詹森药业有限公司 |
可用作sglt2的抑制剂的化合物的制备方法
|
US8163704B2
(en)
|
2009-10-20 |
2012-04-24 |
Novartis Ag |
Glycoside derivatives and uses thereof
|
JP2013523681A
(ja)
|
2010-03-30 |
2013-06-17 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Sglt2インヒビター及びppar−ガンマアゴニストを含む医薬組成物並びにその使用
|
CN108354930A
(zh)
|
2010-05-11 |
2018-08-03 |
詹森药业有限公司 |
包含1-(β-D-吡喃葡萄糖基)-2-噻吩基-甲基苯衍生物的药物制剂
|
CN102970981A
(zh)
*
|
2010-07-06 |
2013-03-13 |
詹森药业有限公司 |
糖尿病协同治疗制剂
|